FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christina Annunziata

Research Profile

Disorders

Anatomy

Procedures

Chemicals & Drugs

Physiology

Occupations

Proteomics

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Jung-min Lee; Lori M Minasian; Anne M Noonan; Jennifer Squires; Bradford J Wood; Minshu Yu; Christina Annunziata; Nilofer S Azad; Katherine R Calvo; John L Hays; Nicole Houston; Elise C Kohn
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
Benjamin M Cherry; Rene Costello; Eric A Engels; Neha Korde; Mary Kwok; Christina Annunziata; Jason Burris; Elisabet Manasanch; Mark J Roschewski; Adriana Zingone; Ola Landgren
Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.
Geoffrey Kim; Junbai Wang; Minshu Yu; Christina Annunziata; Ben Davidson; Ryan Henning; Thea Hetland; Elise C Kohn
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christina Annunziata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jung-min Lee; Lori M Minasian; Anne M Noonan; Jennifer Squires; Bradford J Wood; Minshu Yu; Christina Annunziata; Nilofer S Azad; Katherine R Calvo; John L Hays; Nicole Houston; Elise C Kohn
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
Cancer 2013;119(7):1357-64.
2013: Benjamin M Cherry; Rene Costello; Eric A Engels; Neha Korde; Mary Kwok; Christina Annunziata; Jason Burris; Elisabet Manasanch; Mark J Roschewski; Adriana Zingone; Ola Landgren
Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.
American journal of hematology 2013;88(2):89-92.
2012: Geoffrey Kim; Junbai Wang; Minshu Yu; Christina Annunziata; Ben Davidson; Ryan Henning; Thea Hetland; Elise C Kohn
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.
Cancer 2012;118(6):1543-53.
2010: Christina Annunziata; Helene Tuft Stavnes; Lilach Kleinberg; Aasmund Berner; Lidia F Hernandez; Michael J Birrer; Seth M Steinberg; Ben Davidson; Elise C Kohn
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.
Cancer 2010;116(13):3276-84.
2010: J-M Lee; Gisele Sarosy; Christina Annunziata; Nilofer S Azad; Lori M Minasian; Herb Kotz; J Squires; N Houston; Elise C Kohn
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity.
British journal of cancer 2010;102(3):495-9.
2010: Christina Annunziata; Amanda J Walker; Lori M Minasian; Minshu Yu; Herb Kotz; Bradford J Wood; Katherine R Calvo; Peter Choyke; Daniel Kimm; Seth M Steinberg; Elise C Kohn
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):664-72.
2009: Christina Annunziata; Herb Kotz
Uterine papillary serous carcinoma: a new paradigm for treatment?
Cancer 2009;115(16):3594-6.
2008: Nilofer S Azad; Edwin M Posadas; Virginia E Kwitkowski; Seth M Steinberg; Lokesh Jain; Christina Annunziata; Lori Minasian; Gisele Sarosy; Herbert L Kotz; Ahalya Premkumar; Liang Cao; Deborah McNally; Catherine Chow; Helen X Chen; John J Wright; William D Figg; Elise C Kohn
Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3709-14.
2008: Nilofer S Azad; Christina Annunziata; Seth M Steinberg; Lori M Minasian; Ahalya Premkumar; Catherine Chow; Herb Kotz; Elise C Kohn
Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
Cancer 2008;112(8):1726-32.
2008: Marianne S Poruchynsky; Dan L Sackett; Robert W Robey; Yvona Ward; Christina Annunziata; Tito Fojo
Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition.
Cell cycle (Georgetown, Tex.) 2008;7(7):940-9.
2008: Christina Annunziata; Nilofer S Azad; Amit S Dhamoon; Gordon R Whiteley; Elise C Kohn
Ovarian cancer in the proteomics era.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18 Suppl 1():1-6.
2007: Christina Annunziata; Lilach Kleinberg; Ben Davidson; Aasmund Berner; David Gius; Nana Tchabo; Seth M Steinberg; Elise C Kohn
BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(22 Pt 1):6585-92.
2007: Christina Annunziata; R Eric Davis; Yulia Demchenko; William Bellamy; Ana Gabrea; Fenghuang Zhan; Georg Lenz; Ichiro Hanamura; George Wright; Wenming Xiao; Sandeep Dave; Elaine M Hurt; Bruce Tan; Hong Zhao; Owen Stephens; Madhumita Santra; David R Williams; Lenny Dang; Bart Barlogie; John D Shaughnessy; W Michael Kuehl; Louis M Staudt
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Cancer cell 2007;12(2):115-30.
2007: Elise C Kohn; Nilofer S Azad; Christina Annunziata; Amit S Dhamoon; Gordon R Whiteley
Proteomics as a tool for biomarker discovery.
Disease markers 2007;23(5-6):411-7.
2006: Nilofer S Azad; Nabila Rasool; Christina Annunziata; Lori M Minasian; Gordon R Whiteley; Elise C Kohn
Proteomics in clinical trials and practice: present uses and future promise.
Molecular & cellular proteomics : MCP 2006;5(10):1819-29.
2003: Christina Annunziata; Elise C Kohn
Is there a genomic basis for primary chemoresistance in ovarian cancer?
Gynecologic oncology 2003;90(1):1-2.
2000: Christina Annunziata; Y J Safiran; SG Irving; Usha N Kasid; J Cossman
Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.
Blood 2000;96(8):2841-8.
2000: F M Moscarillo; Christina Annunziata
ECT in a patient with a deep brain-stimulating electrode in place.
The journal of ECT 2000;16(3):287-90.
1999: J Cossman; Christina Annunziata; Steven C Barash; L Staudt; P Dillon; W W He; P Ricciardi-Castagnoli; C A Rosen; KC Carter
Reed-Sternberg cell genome expression supports a B-cell lineage.
Blood 1999;94(2):411-6.
1998: Christina Annunziata; M Hunter Jamerson; E Hunter; Rita M Braziel; Adam Bagg; SG Irving; J Cossman
Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation.
Blood 1998;91(7):2443-51.
1998: J Cossman; Christina Annunziata; Adam Bagg
Reed-Sternberg cell: survival in a hostile sea.
Laboratory investigation; a journal of technical methods and pathology 1998;78(3):229-35.
1997: Christina Annunziata; R Coupland; A Bakhshi; M Raffeld; SG Irving; Adam Bagg; J Cossman
Rearrangement, hypermutation, and possible preferential use of a VH5 gene, VH32, in a Hodgkin's cell line.
Hematopathology and molecular hematology 1997;11(1):19-28.